Figure 3From: Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patientsWe identified 126 patients who were diagnosed and completed the treatment of triple-negative breast cancer; 90 patients were eligible for analysis. ACE = Angiotensin-Converting Enzyme inhibitors.Back to article page